Journal for ImmunoTherapy of Cancer View Homepage


Ontology type: schema:Periodical      Open Access: True


Journal Info

START YEAR

2013

PUBLISHER

BioMed Central

LANGUAGE

en

HOMEPAGE

https://jitc.biomedcentral.com

Recent publications latest 20 shown

  • 2019-12-31 High expression of B7-H3 on stromal cells defines tumor and stromal compartments in epithelial ovarian cancer and is associated with limited immune activation
  • 2019-12-21 Positron emission tomography as an adjuvant diagnostic test in the evaluation of checkpoint inhibitor-associated acute interstitial nephritis
  • 2019-12-20 The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC)
  • 2019-12-19 Interleukin-15 in cancer immunotherapy: IL-15 receptor complex versus soluble IL-15 in a cancer cell-delivered murine leukemia model
  • 2019-12-17 Correction to: Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitis
  • 2019-12-17 Safety and efficacy of immune checkpoint inhibitors (ICIs) in cancer patients with HIV, hepatitis B, or hepatitis C viral infection
  • 2019-12-16 Immunogenic cell death induced by a new photodynamic therapy based on photosens and photodithazine
  • 2019-12-16 Correction to: Immunostimulatory RNA leads to functional reprogramming of myeloid-derived suppressor cells in pancreatic cancer
  • 2019-12-16 High OX-40 expression in the tumor immune infiltrate is a favorable prognostic factor of overall survival in non-small cell lung cancer
  • 2019-12-11 Genetic instability as a driver for immune surveillance
  • 2019-12-11 Chemotherapy accelerates immune-senescence and functional impairments of Vδ2pos T cells in elderly patients affected by liver metastatic colorectal cancer
  • 2019-12-11 Blocking CD47 efficiently potentiated therapeutic effects of anti-angiogenic therapy in non-small cell lung cancer
  • 2019-12-11 Development of a prognostic composite cytokine signature based on the correlation with nivolumab clearance: translational PK/PD analysis in patients with renal cell carcinoma
  • 2019-12-06 Combined innate and adaptive immunotherapy overcomes resistance of immunologically cold syngeneic murine neuroblastoma to checkpoint inhibition
  • 2019-12-05 Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies
  • 2019-12-04 Functional characterization of the selective pan-allele anti-SIRPα antibody ADU-1805 that blocks the SIRPα–CD47 innate immune checkpoint
  • 2019-12-04 A phase Ib study of utomilumab (PF-05082566) in combination with mogamulizumab in patients with advanced solid tumors
  • 2019-12-04 Rapid and sustained response to immune checkpoint inhibition in cutaneous squamous cell carcinoma after allogenic hematopoietic cell transplant for sézary syndrome
  • 2019-12-04 Incidence rates of immune-related adverse events and their correlation with response in advanced solid tumours treated with NIVO or NIVO+IPI: a systematic review and meta-analysis
  • 2019-12-04 Tumor microenvironment dictates regulatory T cell phenotype: Upregulated immune checkpoints reinforce suppressive function
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "contentRating": [
          {
            "author": "snip", 
            "ratingValue": "2.2809998989105225", 
            "type": "Rating"
          }, 
          {
            "author": "sjr", 
            "ratingValue": "5.059999942779541", 
            "type": "Rating"
          }
        ], 
        "description": "

    Journal for ImmunoTherapy of Cancer (JITC) is the premier cancer immunotherapy journal at BMC and the official journal of the Society for Immunotherapy of Cancer (SITC). JITC welcomes basic, translational and clinical research, and literature reviews on any aspect of tumor immunology and cancer immunotherapy. Topics of interest include tumor-host interactions, immune biomarkers, novel therapeutics, and immune-related toxicity. The journal\u2019s full collection, including its seminal guidelines and consensus statements, advances the rapidly evolving field of cancer immunotherapy through dissemination of rigorous peer-reviewed research.

    ", "editor": [ { "familyName": "Romero", "givenName": "Pedro", "type": "Person" } ], "id": "sg:journal.1049249", "inLanguage": [ "en" ], "isAccessibleForFree": true, "issn": [ "2051-1426" ], "license": "Fully Open Access", "name": "Journal for ImmunoTherapy of Cancer", "productId": [ { "name": "dimensions_id", "type": "PropertyValue", "value": [ "49249" ] }, { "name": "lccn_id", "type": "PropertyValue", "value": [ "2013254548" ] }, { "name": "nlm_unique_id", "type": "PropertyValue", "value": [ "101620585" ] }, { "name": "nsd_ids_id", "type": "PropertyValue", "value": [ "497460" ] } ], "publisher": { "name": "BioMed Central", "type": "Organization" }, "publisherImprint": "BioMed Central", "sameAs": [ "https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1049249" ], "sdDataset": "journals", "sdDatePublished": "2022-05-20T07:52", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/journal/journal_0.jsonl", "startYear": "2013", "type": "Periodical", "url": "https://jitc.biomedcentral.com" } ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/journal.1049249'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/journal.1049249'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/journal.1049249'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/journal.1049249'


     

    This table displays all metadata directly associated to this object as RDF triples.

    55 TRIPLES      20 PREDICATES      25 URIs      21 LITERALS      9 BLANK NODES

    Subject Predicate Object
    1 sg:journal.1049249 schema:contentRating N23136c56f06b4681b2cb30707eac36b0
    2 N6ba7f38d991d436da03c1260ebbf913d
    3 schema:description <p><i>Journal for ImmunoTherapy of Cancer (JITC)</i> is the premier cancer immunotherapy journal at BMC and the official journal of the Society for Immunotherapy of Cancer (SITC). JITC welcomes basic, translational and clinical research, and literature reviews on any aspect of tumor immunology and cancer immunotherapy. Topics of interest include tumor-host interactions, immune biomarkers, novel therapeutics, and immune-related toxicity. The journal’s full collection, including its seminal guidelines and consensus statements, advances the rapidly evolving field of cancer immunotherapy through dissemination of rigorous peer-reviewed research.</p>
    4 schema:editor N48313e72f3fa4949a7135b9b969f9b08
    5 schema:inLanguage en
    6 schema:isAccessibleForFree true
    7 schema:issn 2051-1426
    8 schema:license Fully Open Access
    9 schema:name Journal for ImmunoTherapy of Cancer
    10 schema:productId N1caca81bca6e47b3885c6be5af8d2a34
    11 N4098df5e890a495383a5c0ac0393c41b
    12 N658d0c026f75486e90602ace8320de45
    13 N6837cdd875204167b3961605dc8cccac
    14 schema:publisher N7d2b975ccfc6448e9fddec53a42f42e8
    15 schema:publisherImprint BioMed Central
    16 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1049249
    17 schema:sdDatePublished 2022-05-20T07:52
    18 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    19 schema:sdPublisher N4aa64bacc8e6495bbbeb2f2cd755f108
    20 schema:startYear 2013
    21 schema:url https://jitc.biomedcentral.com
    22 sgo:license sg:explorer/license/
    23 sgo:sdDataset journals
    24 rdf:type schema:Periodical
    25 N1caca81bca6e47b3885c6be5af8d2a34 schema:name nsd_ids_id
    26 schema:value 497460
    27 rdf:type schema:PropertyValue
    28 N23136c56f06b4681b2cb30707eac36b0 schema:author Ndcce5a7688f34e96b24b3168ecc09a35
    29 schema:ratingValue 5.059999942779541
    30 rdf:type schema:Rating
    31 N4098df5e890a495383a5c0ac0393c41b schema:name nlm_unique_id
    32 schema:value 101620585
    33 rdf:type schema:PropertyValue
    34 N413f382970d7449e95395d3a0b534297 rdf:first snip
    35 rdf:rest rdf:nil
    36 N48313e72f3fa4949a7135b9b969f9b08 rdf:first N969326f421dc4c67bfe126f0c7b9a921
    37 rdf:rest rdf:nil
    38 N4aa64bacc8e6495bbbeb2f2cd755f108 schema:name Springer Nature - SN SciGraph project
    39 rdf:type schema:Organization
    40 N658d0c026f75486e90602ace8320de45 schema:name lccn_id
    41 schema:value 2013254548
    42 rdf:type schema:PropertyValue
    43 N6837cdd875204167b3961605dc8cccac schema:name dimensions_id
    44 schema:value 49249
    45 rdf:type schema:PropertyValue
    46 N6ba7f38d991d436da03c1260ebbf913d schema:author N413f382970d7449e95395d3a0b534297
    47 schema:ratingValue 2.2809998989105225
    48 rdf:type schema:Rating
    49 N7d2b975ccfc6448e9fddec53a42f42e8 schema:name BioMed Central
    50 rdf:type schema:Organization
    51 N969326f421dc4c67bfe126f0c7b9a921 schema:familyName Romero
    52 schema:givenName Pedro
    53 rdf:type schema:Person
    54 Ndcce5a7688f34e96b24b3168ecc09a35 rdf:first sjr
    55 rdf:rest rdf:nil
     




    Preview window. Press ESC to close (or click here)


    ...